Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesDataMEDS AI, Inc.

DataMEDS AI, Inc.

Healthcare Pharmaceutical Retailers
PortfolioPortfolio WatchlistWatchlist
Company price
1.18 USD -0.04 ( 3.28%)
Last update at 2026-11-06T21:00:00Z
VOLUME
114350
Market Cap
8.30M

Momentum Score

…

TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.14
Low
1.24
High
52 Week Price Range
1.79
Low
21.59
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for DataMEDS AI, Inc. (NASDAQ: MEDS) are limited and do not provide a clear, verifiable description of its core business activities. Because detailed operations and strategy are not well documented in filings and releases, material long-term growth drivers cannot be confirmed from public sources, although some investors may be attracted by its Nasdaq listing and potential exposure to data/AI themes.

Primary investment risks include limited transparency and verifiable operating history, low liquidity and trading volume, potential dilution from future financing, and uncertainty around regulatory compliance and revenue generation.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.22
Dividend Yield
-
Revenue TTM
8.27M
Revenue Per Share
10.83
Gross Profit TTM
4.58M
Debt / Equity
13.10
ROE
-3099.92%
Net Debt
6.95M
ROCE
-282.27%
Diluted EPS TTM
-18.75

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -3.91M -5.32M -2.54M -0.28M 0.01M
Minority interest 0.44M - - - -
Net income -4.31M -4.11M -2.57M -0.41M 0.01M
Selling general administrative 7.05M 8.81M 7.49M 4.38M 2.35M
Gross profit 5.45M 4.75M 5.71M 4.87M 3.38M
Reconciled depreciation 0.20M 0.14M 0.10M 0.09M -
Ebit -2.76M -5.29M -1.78M 0.57M -0.09M
Ebitda -2.54M -5.15M -1.68M 0.66M 0.24M
Depreciation and amortization 0.22M 0.14M 0.10M 0.09M 0.33M
Operating income -2.76M -5.29M -1.78M 0.57M -0.09M
Other operating expenses 14.20M 13.96M 18.90M 6.94M 3.75M
Interest expense 0.34M 0.02M 0.03M 0.05M 0.06M
Interest income 0.02M - - 0.30M 0.06M
Net interest income -0.32M -0.02M -0.03M -0.05M -0.06M
Non recurring - - 0.73M - -
Income tax expense 0.40M -1.20M 0.03M 0.13M -0.15M
Total revenue 11.45M 9.89M 17.12M 7.44M 3.83M
Total operating expenses 8.21M 8.81M 7.49M 4.38M 3.30M
Cost of revenue 6.00M 5.14M 11.42M 2.57M 0.45M
Total other income expense net -1.15M -0.02M -0.76M -0.85M -0.02M
Net income from continuing ops -3.91M -5.32M -2.54M -0.28M 0.01M
Net income applicable to common shares -3.47M -5.32M -2.54M -0.28M 0.01M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 12.53M 3.71M 5.77M 9.79M 5.57M
Intangible assets 8.96M 0.45M - - -
Other current assets 0.48M 0.11M 0.22M 0.15M 0.08M
Total liab 11.99M 3.37M 2.00M 1.11M 1.43M
Total stockholder equity 0.54M 0.76M 3.77M 8.68M 4.14M
Deferred long term liab - - - - 0.09M
Other current liab 1.98M 1.05M 0.27M 0.22M 0.10M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -33.25M -19.72M -16.25M -10.93M -8.40M
Good will - - - 0.00M 0.73M
Other assets - 0.05M 0.06M 0.41M 0.11M
Cash 0.15M 1.13M 3.12M 5.92M 2.87M
Total current liabilities 11.56M 2.15M 0.93M 0.84M 0.52M
Current deferred revenue 0.82M - - 0.01M -
Net debt 6.95M 0.45M -1.87M -5.29M -1.87M
Short term debt 6.67M 0.36M 0.18M 0.36M 0.09M
Short long term debt 6.53M 0.17M - 0.23M -
Short long term debt total 7.10M 1.58M 1.25M 0.63M 1.00M
Other stockholder equity 33.79M 20.48M 20.02M 19.61M 12.54M
Property plant equipment - 1.12M 1.33M 0.55M 0.93M
Total current assets 2.75M 2.09M 4.37M 9.22M 3.80M
Net tangible assets - 0.31M 3.77M 8.68M 3.41M
Net receivables 2.49M 0.73M 0.98M 1.89M 0.79M
Long term debt 0.03M 0.33M - - 0.23M
Inventory 0.00M 0.12M 0.06M 1.26M 0.06M
Accounts payable 2.08M 0.73M 0.48M 0.26M 0.33M
Common stock total equity - - - 0.00M 0.00M
Retained earnings total equity - - - -10.93M -
Non currrent assets other 0.01M 0.05M 0.06M 0.02M 0.11M
Non current assets total 9.78M 1.62M 1.39M 0.57M 1.77M
Capital lease obligations 0.55M 1.08M 1.25M 0.40M 0.77M
Long term debt total - - - - 0.23M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.43M -0.02M -0.04M -0.33M -0.27M
Change to liabilities 0.25M 0.22M -0.03M -0.15M 0.10M
Total cashflows from investing activities -0.43M -0.02M -0.04M -0.33M -0.27M
Net borrowings - -0.23M -0.23M -0.26M -0.12M
Total cash from financing activities -0.04M -0.21M 5.30M 2.19M 0.68M
Change to operating activities -0.25M 0.83M -1.12M -0.17M -0.01M
Net income -3.91M -5.32M -2.54M -0.28M 0.01M
Change in cash -1.99M -2.80M 3.05M 2.00M 0.69M
Begin period cash flow 3.12M 5.92M 2.87M 0.87M 0.18M
End period cash flow 1.13M 3.12M 5.92M 2.87M 0.87M
Total cash from operating activities -1.53M -2.57M -2.21M 0.14M 0.27M
Issuance of capital stock 0.13M 0.00M 5.99M 2.46M 0.80M
Depreciation 0.20M 0.14M 0.10M 0.09M 0.09M
Other cashflows from investing activities - - - -0.25M -0.25M
Change to inventory -0.06M 0.83M -2.42M 0.02M -0.00M
Change to account receivables 0.50M -0.79M -0.02M -0.37M -0.00M
Sale purchase of stock - - 5.30M 2.46M 0.80M
Other cashflows from financing activities -0.17M 0.02M -0.69M 0.00M -0.27M
Change to netincome 1.31M 1.53M 3.82M 1.00M 0.18M
Capital expenditures 0.45M 0.02M 0.04M 0.08M 0.02M
Change receivables - - -1.11M - -
Cash flows other operating - - 0.04M - -
Cash and cash equivalents changes - - 3.05M - -
Change in working capital 0.44M 1.08M -3.60M -0.67M 0.08M
Other non cash items 1.75M 1.53M 3.82M 1.00M 0.18M
Free cash flow -1.98M -2.59M -2.25M 0.06M 0.26M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MEDS
DataMEDS AI, Inc.		 -0.04
3.28%		 1.18 - 21.83 0.94 0.76 1.62 -5.52
JDHIF
JD Health International Inc		 -
-%		 4.79 15.09 15.11 0.18 1.52 0.59 6.26
ALBBY
Alibaba Health Information Technology Limited		 -
-%		 7.65 34.43 19.84 0.29 3.79 1.73 25.72
RADLY
Raia Drogasil SA ADR		 0.09
3.35%		 2.78 22.35 24.69 0.14 4.59 0.90 10.93
ALBHF
Alibaba Health Information Technology Limited		 -
-%		 0.33 17.35 16.69 0.16 2.11 0.89 13.04

Profile*

DataMEDS AI, Inc.

TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.

2420 Brunello Trace, Lutz, FL, United States, 33558

800 261 0281

https://www.trxadehealth.com

8

Name Title Year Born
Mr. Surendra K. Ajjarapu Founder, Chairman, CEO & Sec. 1971
Mr. Prashant Patel Founder, Pres, COO & Director 1974
Ms. Janet Huffman CFO & Principal Accounting Officer 1972
Dr. Ramesh Kenchappa Chief Scientific Officer NA
Mr. David M. Saslow Inhouse Counsel NA
Mr. Jariel Morales Exec. VP NA
Mr. Surendra K. Ajjarapu Founder, Chairman, CEO & Secretary 1971
Mr. Prashant Patel R.Ph. Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director 1974
Mr. David M. Saslow Esq. Inhouse Counsel NA
Mr. Jariel Morales Executive Vice President NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…